ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

6.26%

$5.60

Market Cap $86.68M

Healthcare Medical Devices

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AVR	SAVR Clinical Trial	PRICE SENSITIVE	22/01/20	137.57KB	Share
AVR	Appendix 3B		13/01/20	253.6KB	Share
AVR	Appendix 3B		11/12/19	254.85KB	Share
AVR	Update to LeMaitre Vascular deal	PRICE SENSITIVE	09/12/19	181.07KB	Share
AVR	Appendix 3B		26/11/19	255.16KB	Share
AVR	Response to ASX Price and Volume Query	PRICE SENSITIVE	19/11/19	703.39KB	Share
AVR	ADAPT Carve Out Financial Statements		31/10/19	850.77KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/19	282KB	Share
AVR	CardioCel and VascuCel LeMaitre deal clarification		15/10/19	74.69KB	Share
AVR	Reinstatement to Official Quotation	PRICE SENSITIVE	14/10/19	71.87KB	Share
AVR	CardioCel and VascuCel rights sold to LeMaitre Vascular	PRICE SENSITIVE	14/10/19	111.96KB	Share
AVR	Extension for Voluntary Suspension		30/09/19	78.88KB	Share
AVR	CARDIOCEL 3D APPROVED FOR SALE IN ISRAEL		04/09/19	125.17KB	Share
AVR	Appendix 3B		02/09/19	255.03KB	Share
AVR	Extension for Voluntary Suspension	PRICE SENSITIVE	02/09/19	78.92KB	Share
AVR	Appendix 4D and Half Yearly Financial Report	PRICE SENSITIVE	23/08/19	1001.93KB	Share
AVR	Suspension from Official Quotation - Annual Listing Fee	PRICE SENSITIVE	22/08/19	440.19KB	Share
AVR	Response to ASX Appendix 4C Query	PRICE SENSITIVE	15/08/19	699.37KB	Share
AVR	Notice to terminate distribution agreement	PRICE SENSITIVE	08/08/19	75.71KB	Share
AVR	Change in substantial holding		07/08/19	233.29KB	Share
AVR	Extension for Voluntary Suspension		05/08/19	79.2KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/19	232.24KB	Share
AVR	Appendix 3B		16/07/19	246.94KB	Share
AVR	Extension for Voluntary Suspension		01/07/19	78.88KB	Share
AVR	POSITIVE DATA ON CARDIOCEL PUBLISHED IN LEADING JOURNAL		24/06/19	148.81KB	Share
AVR	Extension for Voluntary Suspension		04/06/19	78.91KB	Share
AVR	BTC: Completion of acquisition of Hospital Infusion Business		31/05/19	43.37KB	Share
AVR	AHZ completes sale of part of Infusion business	PRICE SENSITIVE	31/05/19	93.28KB	Share
AVR	Appendix 3Z		31/05/19	242.2KB	Share
AVR	Resignation of non-executive director		31/05/19	92.61KB	Share
AVR	Extension for Voluntary Suspension		21/05/19	78.89KB	Share
AVR	Appendix 3B		16/05/19	242.82KB	Share
AVR	Results of 2019 Annual General Meeting		14/05/19	211.62KB	Share
AVR	2019 AGM Presentation	PRICE SENSITIVE	14/05/19	2.59MB	Share
AVR	BTC: BTC health to acquire Hospital Infusion Business		13/05/19	44.81KB	Share
AVR	Admedus to divest part of Infusion business	PRICE SENSITIVE	13/05/19	121.62KB	Share
AVR	Facility Agreement with SIO Partners LP	PRICE SENSITIVE	08/05/19	121.62KB	Share
AVR	Extension for Voluntary Suspension		07/05/19	78.86KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	26/04/19	267.15KB	Share
AVR	Extension for Voluntary Suspension		23/04/19	79.4KB	Share
AVR	Transaction Terminated and Subsidiary Appoints Administrator	PRICE SENSITIVE	23/04/19	94.56KB	Share
AVR	Response to ASX Aware Query	PRICE SENSITIVE	23/04/19	270.52KB	Share
AVR	Suspension from Official Quotation	PRICE SENSITIVE	17/04/19	290.06KB	Share
AVR	Trading Halt	PRICE SENSITIVE	15/04/19	284.95KB	Share
AVR	Appendix 4G		12/04/19	185.02KB	Share
AVR	Annual Report to shareholders		12/04/19	4.82MB	Share
AVR	Notice of General Meeting/Proxy Form		12/04/19	1.76MB	Share
AVR	Response to ASX Price and Volume Query	PRICE SENSITIVE	10/04/19	480.15KB	Share
AVR	Share Sale Agreement to sell Admedus Vaccines	PRICE SENSITIVE	10/04/19	104.82KB	Share
AVR	Trading Halt	PRICE SENSITIVE	10/04/19	150.44KB	Share
AVR	Pause In Trading	PRICE SENSITIVE	10/04/19	115.22KB	Share
AVR	CardioCel 3D and VascuCel European regulatory approval		11/03/19	126.32KB	Share
AVR	Appendix 3B		05/03/19	238.46KB	Share
AVR	Preliminary Final Report for period to 31 December 2018	PRICE SENSITIVE	01/03/19	157.47KB	Share
AVR	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	01/03/19	1.69MB	Share
AVR	Response to ASX Appendix 4C Query	PRICE SENSITIVE	20/02/19	259.97KB	Share
AVR	Promising Interim Results from TAVR Animal Study	PRICE SENSITIVE	19/02/19	100.82KB	Share
AVR	Change of Registered Address		30/01/19	74.83KB	Share
AVR	Change in substantial holding		21/01/19	485.25KB	Share
AVR	Becoming a substantial holder		21/01/19	16.35MB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	21/01/19	219.42KB	Share
AVR	Change of Director's Interest Notice		21/12/18	885.83KB	Share
AVR	Initial Director's Interest Notice		19/12/18	165.71KB	Share
AVR	Initial Director's Interest Notice		19/12/18	169.66KB	Share
AVR	Appendix 3B		18/12/18	421.12KB	Share
AVR	NOTICE OF DELAY OF ALLOTMENT IN SHARES		17/12/18	79.08KB	Share
AVR	Entitlement Offer Shortfall Notice		14/12/18	85.35KB	Share
AVR	Director Appointments		12/12/18	83.82KB	Share
AVR	Despatch of rights issue offer documents		04/12/18	79.63KB	Share
AVR	Despatch of letters to eligible and ineligible shareholders		04/12/18	1.42MB	Share
AVR	Chief Medical Officer Appointment		04/12/18	81.93KB	Share
AVR	Reinstatement to Official Quotation	PRICE SENSITIVE	28/11/18	68.65KB	Share
AVR	Appendix 3B		28/11/18	456.4KB	Share
AVR	Admedus Prospectus - rights issue	PRICE SENSITIVE	28/11/18	655.56KB	Share
AVR	Admedus launches rights issue	PRICE SENSITIVE	28/11/18	185.75KB	Share
AVR	Interim CFO Appointment		26/11/18	80.63KB	Share
AVR	Restructure of Australian Management Team		19/11/18	75.36KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	01/11/18	365.86KB	Share
AVR	Director and Company Secretary Appointment		31/10/18	495.22KB	Share
AVR	Final Directors Interest Notice		29/10/18	198.01KB	Share
AVR	Director Appointment/Resignation		29/10/18	138.99KB	Share
AVR	Director Appointment/Resignation		04/10/18	511.7KB	Share
AVR	Correction cover letter Notice of Initial Substantial Holder		18/09/18	23.8KB	Share
AVR	Becoming a substantial holder		17/09/18	9.09MB	Share
AVR	Becoming a substantial holder		17/09/18	8.66MB	Share
AVR	Appendix 3B - Star Bright Placement Issue	PRICE SENSITIVE	05/09/18	844.58KB	Share
AVR	Appendix 3B		03/09/18	868.65KB	Share
AVR	Extension for Voluntary Suspension		03/09/18	210.35KB	Share
AVR	Appendix 4D and Half Yearly Financial Report	PRICE SENSITIVE	03/09/18	1.02MB	Share
AVR	Admedus Secures Strategic Investor	PRICE SENSITIVE	03/09/18	242.06KB	Share
AVR	Extension of Voluntary Suspension		20/08/18	108.4KB	Share
AVR	Extension for voluntary suspension		13/08/18	27.46KB	Share
AVR	Distribution agreement renewed for infusion supply chain	PRICE SENSITIVE	09/08/18	30.8KB	Share
AVR	Extension of Voluntary Suspension		08/08/18	217.2KB	Share
AVR	Voluntary Suspension	PRICE SENSITIVE	06/08/18	276.07KB	Share
AVR	Trading Halt Announcement - System Upgrade	PRICE SENSITIVE	06/08/18	220.36KB	Share
AVR	Trading Halt	PRICE SENSITIVE	02/08/18	636.94KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/18	269.99KB	Share
AVR	Major Milestone for TAVR As Trials Commence	PRICE SENSITIVE	11/07/18	615.62KB	Share
AVR	New distribution agreement signed for Italy	PRICE SENSITIVE	09/07/18	32.52KB	Share

AVR SAVR Clinical Trial
22/01/20	PRICE SENSITIVE	137.57KB	Share
AVR Appendix 3B
13/01/20		253.6KB	Share
AVR Appendix 3B
11/12/19		254.85KB	Share
AVR Update to LeMaitre Vascular deal
09/12/19	PRICE SENSITIVE	181.07KB	Share
AVR Appendix 3B
26/11/19		255.16KB	Share
AVR Response to ASX Price and Volume Query
19/11/19	PRICE SENSITIVE	703.39KB	Share
AVR ADAPT Carve Out Financial Statements
31/10/19		850.77KB	Share
AVR Appendix 4C - quarterly
31/10/19	PRICE SENSITIVE	282KB	Share
AVR CardioCel and VascuCel LeMaitre deal clarification
15/10/19		74.69KB	Share
AVR Reinstatement to Official Quotation
14/10/19	PRICE SENSITIVE	71.87KB	Share
AVR CardioCel and VascuCel rights sold to LeMaitre Vascular
14/10/19	PRICE SENSITIVE	111.96KB	Share
AVR Extension for Voluntary Suspension
30/09/19		78.88KB	Share
AVR CARDIOCEL 3D APPROVED FOR SALE IN ISRAEL
04/09/19		125.17KB	Share
AVR Appendix 3B
02/09/19		255.03KB	Share
AVR Extension for Voluntary Suspension
02/09/19	PRICE SENSITIVE	78.92KB	Share
AVR Appendix 4D and Half Yearly Financial Report
23/08/19	PRICE SENSITIVE	1001.93KB	Share
AVR Suspension from Official Quotation - Annual Listing Fee
22/08/19	PRICE SENSITIVE	440.19KB	Share
AVR Response to ASX Appendix 4C Query
15/08/19	PRICE SENSITIVE	699.37KB	Share
AVR Notice to terminate distribution agreement
08/08/19	PRICE SENSITIVE	75.71KB	Share
AVR Change in substantial holding
07/08/19		233.29KB	Share
AVR Extension for Voluntary Suspension
05/08/19		79.2KB	Share
AVR Appendix 4C - quarterly
31/07/19	PRICE SENSITIVE	232.24KB	Share
AVR Appendix 3B
16/07/19		246.94KB	Share
AVR Extension for Voluntary Suspension
01/07/19		78.88KB	Share
AVR POSITIVE DATA ON CARDIOCEL PUBLISHED IN LEADING JOURNAL
24/06/19		148.81KB	Share
AVR Extension for Voluntary Suspension
04/06/19		78.91KB	Share
AVR BTC: Completion of acquisition of Hospital Infusion Business
31/05/19		43.37KB	Share
AVR AHZ completes sale of part of Infusion business
31/05/19	PRICE SENSITIVE	93.28KB	Share
AVR Appendix 3Z
31/05/19		242.2KB	Share
AVR Resignation of non-executive director
31/05/19		92.61KB	Share
AVR Extension for Voluntary Suspension
21/05/19		78.89KB	Share
AVR Appendix 3B
16/05/19		242.82KB	Share
AVR Results of 2019 Annual General Meeting
14/05/19		211.62KB	Share
AVR 2019 AGM Presentation
14/05/19	PRICE SENSITIVE	2.59MB	Share
AVR BTC: BTC health to acquire Hospital Infusion Business
13/05/19		44.81KB	Share
AVR Admedus to divest part of Infusion business
13/05/19	PRICE SENSITIVE	121.62KB	Share
AVR Facility Agreement with SIO Partners LP
08/05/19	PRICE SENSITIVE	121.62KB	Share
AVR Extension for Voluntary Suspension
07/05/19		78.86KB	Share
AVR Appendix 4C - quarterly
26/04/19	PRICE SENSITIVE	267.15KB	Share
AVR Extension for Voluntary Suspension
23/04/19		79.4KB	Share
AVR Transaction Terminated and Subsidiary Appoints Administrator
23/04/19	PRICE SENSITIVE	94.56KB	Share
AVR Response to ASX Aware Query
23/04/19	PRICE SENSITIVE	270.52KB	Share
AVR Suspension from Official Quotation
17/04/19	PRICE SENSITIVE	290.06KB	Share
AVR Trading Halt
15/04/19	PRICE SENSITIVE	284.95KB	Share
AVR Appendix 4G
12/04/19		185.02KB	Share
AVR Annual Report to shareholders
12/04/19		4.82MB	Share
AVR Notice of General Meeting/Proxy Form
12/04/19		1.76MB	Share
AVR Response to ASX Price and Volume Query
10/04/19	PRICE SENSITIVE	480.15KB	Share
AVR Share Sale Agreement to sell Admedus Vaccines
10/04/19	PRICE SENSITIVE	104.82KB	Share
AVR Trading Halt
10/04/19	PRICE SENSITIVE	150.44KB	Share
AVR Pause In Trading
10/04/19	PRICE SENSITIVE	115.22KB	Share
AVR CardioCel 3D and VascuCel European regulatory approval
11/03/19		126.32KB	Share
AVR Appendix 3B
05/03/19		238.46KB	Share
AVR Preliminary Final Report for period to 31 December 2018
01/03/19	PRICE SENSITIVE	157.47KB	Share
AVR Appendix 4E and Preliminary Final Report
01/03/19	PRICE SENSITIVE	1.69MB	Share
AVR Response to ASX Appendix 4C Query
20/02/19	PRICE SENSITIVE	259.97KB	Share
AVR Promising Interim Results from TAVR Animal Study
19/02/19	PRICE SENSITIVE	100.82KB	Share
AVR Change of Registered Address
30/01/19		74.83KB	Share
AVR Change in substantial holding
21/01/19		485.25KB	Share
AVR Becoming a substantial holder
21/01/19		16.35MB	Share
AVR Appendix 4C - quarterly
21/01/19	PRICE SENSITIVE	219.42KB	Share
AVR Change of Director's Interest Notice
21/12/18		885.83KB	Share
AVR Initial Director's Interest Notice
19/12/18		165.71KB	Share
AVR Initial Director's Interest Notice
19/12/18		169.66KB	Share
AVR Appendix 3B
18/12/18		421.12KB	Share
AVR NOTICE OF DELAY OF ALLOTMENT IN SHARES
17/12/18		79.08KB	Share
AVR Entitlement Offer Shortfall Notice
14/12/18		85.35KB	Share
AVR Director Appointments
12/12/18		83.82KB	Share
AVR Despatch of rights issue offer documents
04/12/18		79.63KB	Share
AVR Despatch of letters to eligible and ineligible shareholders
04/12/18		1.42MB	Share
AVR Chief Medical Officer Appointment
04/12/18		81.93KB	Share
AVR Reinstatement to Official Quotation
28/11/18	PRICE SENSITIVE	68.65KB	Share
AVR Appendix 3B
28/11/18		456.4KB	Share
AVR Admedus Prospectus - rights issue
28/11/18	PRICE SENSITIVE	655.56KB	Share
AVR Admedus launches rights issue
28/11/18	PRICE SENSITIVE	185.75KB	Share
AVR Interim CFO Appointment
26/11/18		80.63KB	Share
AVR Restructure of Australian Management Team
19/11/18		75.36KB	Share
AVR Appendix 4C - quarterly
01/11/18	PRICE SENSITIVE	365.86KB	Share
AVR Director and Company Secretary Appointment
31/10/18		495.22KB	Share
AVR Final Directors Interest Notice
29/10/18		198.01KB	Share
AVR Director Appointment/Resignation
29/10/18		138.99KB	Share
AVR Director Appointment/Resignation
04/10/18		511.7KB	Share
AVR Correction cover letter Notice of Initial Substantial Holder
18/09/18		23.8KB	Share
AVR Becoming a substantial holder
17/09/18		9.09MB	Share
AVR Becoming a substantial holder
17/09/18		8.66MB	Share
AVR Appendix 3B - Star Bright Placement Issue
05/09/18	PRICE SENSITIVE	844.58KB	Share
AVR Appendix 3B
03/09/18		868.65KB	Share
AVR Extension for Voluntary Suspension
03/09/18		210.35KB	Share
AVR Appendix 4D and Half Yearly Financial Report
03/09/18	PRICE SENSITIVE	1.02MB	Share
AVR Admedus Secures Strategic Investor
03/09/18	PRICE SENSITIVE	242.06KB	Share
AVR Extension of Voluntary Suspension
20/08/18		108.4KB	Share
AVR Extension for voluntary suspension
13/08/18		27.46KB	Share
AVR Distribution agreement renewed for infusion supply chain
09/08/18	PRICE SENSITIVE	30.8KB	Share
AVR Extension of Voluntary Suspension
08/08/18		217.2KB	Share
AVR Voluntary Suspension
06/08/18	PRICE SENSITIVE	276.07KB	Share
AVR Trading Halt Announcement - System Upgrade
06/08/18	PRICE SENSITIVE	220.36KB	Share
AVR Trading Halt
02/08/18	PRICE SENSITIVE	636.94KB	Share
AVR Appendix 4C - quarterly
31/07/18	PRICE SENSITIVE	269.99KB	Share
AVR Major Milestone for TAVR As Trials Commence
11/07/18	PRICE SENSITIVE	615.62KB	Share
AVR New distribution agreement signed for Italy
09/07/18	PRICE SENSITIVE	32.52KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.60		Change 0.330(6.26%)		Mkt cap ! $86.68M

Open	High	Low	Value	Volume
$5.50	$5.60	$5.30	$89.45K	16.14K

Buyers (Bids)

No.	Vol.	Price($)
1	103	$5.30

Sellers (Offers)

Price($)	Vol.	No.
$5.98	992	1

View Market Depth

No.	Vol.	Price($)
1	103	5.300
1	920	5.270
1	613	5.240
1	576	5.200
1	20000	5.150

Price($)	Vol.	No.
5.980	992	1
5.990	3500	1
6.000	3719	2
6.050	20000	1
6.500	230	2

Last trade - 15.29pm 22/08/2025 (20 minute delay)


Last $5.59		Change 0.330 ( 4.68 %)
Open	High	Low	Volume
$5.59	$5.59	$5.29	3526
Last updated 15.28pm 22/08/2025 ?

AVR (ASX) Chart

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

Corporate Spotlight
Not Yet Available